Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"
Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Apalutamide","url":"https:\/\/www.ortaakarsu.net\/?page_id=12325","facts":[{"label":"Active ingredient \/ generic name","value":"apalutamide"},{"label":"ATC code","value":"L02BB05"},{"label":"Administration route","value":"Oral"}]},{"title":"Chlorpromazine","url":"https:\/\/www.ortaakarsu.net\/?page_id=12337","facts":[{"label":"Active ingredient \/ generic name","value":"chlorpromazine"},{"label":"ATC code","value":"N05AA01"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"EMA Erleada SmPC; retrieved 2026-11-02; SmPC 4.4; EMA Xtandi package leaflet section 2 (named partners)"}],"sources":[{"label":"Apalutamide EMA product information: enzyme-induction evidence","url":"https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/erleada-epar-product-information_en.pdf"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:28843","available":true}}